This archive contains the following articles listed by volume, issue and page number:

Volume 12, 2008 Articles

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jan/Feb 2008 Pg. 4	PreScription: Year Number 12…And Still Much Work to Do Author(s): Allen Loyd V Jr
Jan/Feb 2008 Pg. 8-14	Intravitreal Bevacizumab for Choroidal Neovascularization in Age-Related Macular Degeneration Author(s): Dib Jean G, Abdulmohsin Saud
Jan/Feb 2008 Pg. 16-27	Cancer-Related Terminology: Glossaries for Compounding Pharmacists and Their Clients Author(s): Williams LaVonn A
Jan/Feb 2008 Pg. 28-37	Hospice and Compounding Pharmacy: Once Inseperable Author(s): Williams LaVonn A
Jan/Feb 2008 Pg. 38-47 View Sample	Disposing of Expired Drugs and Chemicals: New Options for Compounders Author(s): Vail Jane
Jan/Feb 2008 Pg. 48-49	Websites: Keeping Current in 2008 Author(s): Storey Patricia L
Jan/Feb 2008 Pg. 50-53	Quality-Control Analytical Methods: Stability Versus Potency Testing: The Madness is in the Method Author(s): Kupiec Thomas C, Skinner Rodney, Lanier Lance
Jan/Feb 2008 Pg. 62	Calculations: Compounding for Cancer Patients Author(s): Stockton Shelly J
Jan/Feb 2008 Pg. 63	Standard Operating Procedure: Compliance with the Health Insurance Portability and Accountability Act (HIPAA) of 1996 Author(s): Allen Loyd V Jr
Jan/Feb 2008 Pg. 64	Cyclosporine Topical Gel Author(s): Allen Loyd V Jr
Jan/Feb 2008 Pg. 65	Diclofenac Sodium 1% Soft-Patch Gel Author(s): Allen Loyd V Jr
Jan/Feb 2008 Pg. 66	Diclofenac Sodium 1% Soft-Patch Lipophilic Gel Author(s): Allen Loyd V Jr
Jan/Feb 2008 Pg. 54-60	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 5: Verification of Accuracy, Sterility, and Sterilization of Compounded Preparations Author(s): Allen Loyd V Jr, Okeke Claudia C
Jan/Feb 2008 Pg. 67	Diltiazem 5% in Lipoderm, Veterinary Author(s): Allen Loyd V Jr
Jan/Feb 2008 Pg. 68	Emetine Hydrochloride 30-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2008 Pg. 69	Flosulide 10-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2008 Pg. 70	Pentoxifylline 20-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2008 Pg. 71	Piroxicam 1% Soft-Patch Lipophilic Gel Author(s): Allen Loyd V Jr
Jan/Feb 2008 Pg. 72	Piroxicam 1% Soft-Patch Topical Gel Author(s): Allen Loyd V Jr
Jan/Feb 2008 Pg. 73	Trimethoprim 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2008 Pg. 74-82	Specialty Compounding for Improved Patient Care: 2006 National Survey of Compounding Pharmacists Author(s): Huffman DC, Holmes Erin R
Jan/Feb 2008 Pg. 83-85	Room Temperature Stability of Injectable Succinylcholine Dichloride Author(s): Roy Julie J, Boismenu Daniel, Mamer Orval A, Nguyen Bao T, Forest Jean-Marc, Hildgen Patrice
Jan/Feb 2008 Pg. 86	2007 Reviewers Author(s):
Jan/Feb 2008 Pg. 87	PostScription: Consumer Options for Disposal of Unused Medications Author(s): Vail Jane
Mar/Apr 2008 Pg. 92	PreScription: Compounding Around the World Author(s): Allen Loyd V Jr
Mar/Apr 2008 Pg. 94-99	Current Compounding Practices in Europe Author(s): Carvalho Maria, Tuleu Catherine, Taylor Kevin MG
Mar/Apr 2008 Pg. 102-115	Compounding Around the World Author(s): Vail Jane
Mar/Apr 2008 Pg. 116-120	Establishing a Quality-Assurance Program for Hospital Compounding Author(s): McElhiney Linda F
Mar/Apr 2008 Pg. 122-127	Hormone Therapy: It's Time for a Second Opinion Author(s): Collins Joseph J, Ahlgrimm Maria
Mar/Apr 2008 Pg. 128-129	Newsletters: An Essential Marketing Tool Author(s): Storey Patricia L
Mar/Apr 2008 Pg. 130-135	Quality-Control Analytical Methods: Minimizing the Probability of Out-of-Specification Preparations: Results that Make You Say…Hmmm! Author(s): Odegard Russell D
Mar/Apr 2008 Pg. 145	Calculations Author(s): Stockton Shelly J
Mar/Apr 2008 Pg. 146	Acyclovir 5% Topical Ointment Author(s): Allen Loyd V Jr
Mar/Apr 2008 Pg. 156-160	Compatibility and Stability of Palonosetron Hydrochloride with Four Neuromuscular Blocking Agents During Simulated Y-Site Administration Author(s): Trusley Craig, Ben Michel, Kupiec Thomas C, Trissel Lawrence A
Mar/Apr 2008 Pg. 161-162	Chemical Stability of Tramadol Hydrochloride Injection Author(s): Gupta Vishnu D
Mar/Apr 2008 Pg. 163-169	Pharmaceutical Development of Enteric-Release Hard Gelatin Capsules in the Compounding Setting Author(s): de Oliveira Ferreira Anderson, Holandino Carla
Mar/Apr 2008 Pg. 174-175	PostScription: Accreditation by the Pharmacy Compounding Accreditation Board: Raising the Bar for Patient Care Author(s): Murry Tom
Mar/Apr 2008 Pg. 136-144	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 6: 2008 Revisions to Chapter <797> Author(s): Allen Loyd V Jr, Okeke Claudia C
Mar/Apr 2008 Pg. 147	Alum 6.5% Topical Cream Author(s): Allen Loyd V Jr
Mar/Apr 2008 Pg. 148	Aminacrine Hydrochloride 0.1% Cream Author(s): Allen Loyd V Jr
Mar/Apr 2008 Pg. 149	Butesin Picrate 1% ointment Author(s): Allen Loyd V Jr
Mar/Apr 2008 Pg. 150	Carbamazepine Topical Preparations Author(s): Allen Loyd V Jr
Mar/Apr 2008 Pg. 151	Chlorhexidine Gel Author(s): Allen Loyd V Jr
Mar/Apr 2008 Pg. 152	EDTA 1% Cream Author(s): Allen Loyd V Jr
Mar/Apr 2008 Pg. 153	Erythromycin 1% and Neomycin Sulfate Ointment Author(s): Allen Loyd V Jr
Mar/Apr 2008 Pg. 154	Heparin Gel-Cream Author(s): Allen Loyd V Jr
Mar/Apr 2008 Pg. 155	Hydrogen Peroxide 8% Cream Author(s): Allen Loyd V Jr
Mar/Apr 2008 Pg. 170-173	Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration Author(s): Kupiec Thomas C, Ben Michel, Trusley Craig, Trissel Lawrence A
May/Jun 2008 Pg. 252-257	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 7: Microbial Contamination Risk Levels, 12-Hour Use, and Immediate Use Author(s): Allen Loyd V Jr, Okeke Claudia C
May/Jun 2008 Pg. 258	Calculations Author(s): Stockton Shelly J
May/Jun 2008 Pg. 259	Standard Operating Procedure: Dealing with Patients Experiencing Pain: Presenting without a Prescription Author(s): Allen Loyd V Jr
May/Jun 2008 Pg. 260	African Scalp Lotion Author(s): Allen Loyd V Jr
May/Jun 2008 Pg. 261	Benzyl Benzoate Lotion Author(s): Allen Loyd V Jr
May/Jun 2008 Pg. 262	Calcium Gluconate 2.5% Topical Gel Author(s): Allen Loyd V Jr
May/Jun 2008 Pg. 263	Lubricating Gel Author(s): Allen Loyd V Jr
May/Jun 2008 Pg. 264	Meloxicam 0.3% Topical Gel Author(s): Allen Loyd V Jr
May/Jun 2008 Pg. 265	Miconazole Nitrate 2%, Deoxy-D-Glucose 0.2%, and Hydrocortisone 0.4% Lip Balm Author(s): Allen Loyd V Jr
May/Jun 2008 Pg. 266	Potassium Nitrate/Benzocaine/Tetracaine Dental Gel Author(s): Allen Loyd V Jr
May/Jun 2008 Pg. 267	Promethazine Hydrochloride 2.5-mg/mL Rectal Solution Author(s): Allen Loyd V Jr
May/Jun 2008 Pg. 268	Tolnaftate 1% Antifungal Microemulsion Author(s): Allen Loyd V Jr
May/Jun 2008 Pg. 269	Valsartan 4-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 2008 Pg. 274-275	Chemical Stability of Naltrexone Hydrochloride Injection Author(s): Gupta Vishnu D
May/Jun 2008 Pg. 279	PostScription: A Contemporary Perspective on Compounding Education Author(s): Maine Lucinda L
May/Jun 2008 Pg. 216-229	Microbial Air-Sampling Equipment, Part 1: Meeting United States Pharmacopeia Chapter <797> Standards Author(s): Kastango Eric S
May/Jun 2008 Pg. 230-233	Communication with Pharmacy Technicians: How to Reduce Stress and Improve Pharmacy Operations Author(s): Fyke Jeremy P, Hoffman Mary F
May/Jun 2008 Pg. 234-236	Obtaining Accreditation by the Pharmacy Compounding Accreditation Board, Part 3: Developing a Program of Quality Assurance and Continuous Quality Improvement Author(s): Cabaleiro Joe
May/Jun 2008 Pg. 180	PreScription: Pain! Author(s): Allen Loyd V Jr
May/Jun 2008 Pg. 182-190	Topical Treatment of Neuropathic Pain Author(s): Vadaurri Vince
May/Jun 2008 Pg. 192-197	Compounded Local Anesthetics to Minimize Pain from Medical Procedures Author(s): McElhiney Linda F
May/Jun 2008 Pg. 200-207	Dilution and Compounding of Ziconotide for Intrathecal Administration Author(s): Buchta Tony, Fakata Keri, Stuart William
May/Jun 2008 Pg. 208-212	Pharmacy Compounding at the University of Connecticut: Secundum Artem et Scientia Author(s): Scagliarini Meghan, Bogner Robin H
May/Jun 2008 Pg. 213-215	Developing and Implementing a Clinical Pharmacy Rotation in a Community Compounding Pharmacy Author(s): Walkup Kenny R
May/Jun 2008 Pg. 238-241	Litigating the Legality of Compounding: The Medical Center Pharmacy Case Author(s): Gibbs Jeffrey N
May/Jun 2008 Pg. 242-243	Developing a Niche Marketing Strategy Author(s): Storey Patricia L
May/Jun 2008 Pg. 244-246	Web 2.0 and Health 2.0: Are You In? Author(s): Felkey Bill G
May/Jun 2008 Pg. 247-251	A Process Verification Model for Quality Assurance in a Compounding Pharmacy Author(s): Zolner William J
May/Jun 2008 Pg. 270-273	Evaluation of the Percutaneous Absorption of Promethazine Hydrochloride, In Vitro, Using the Human Ex Vivo Skin Model Author(s): Bassani August S, Banov Daniel, Lehman Paul A
May/Jun 2008 Pg. 276-278	Compatibility of Caspofungin Acetate Injection with Other Drugs During Simulated Y-Site Coadministration Author(s): Chan Pak, Heatherly Kathy, Kupiec Thomas C, Trissel Lawrence A
Jul/Aug 2008 Pg. 284	PreScription: First Estriol, Then What? Author(s): Allen Loyd V Jr
Jul/Aug 2008 Pg. 344-353	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 8; Stability and Beyond-Use Dating Author(s): Allen Loyd V Jr, Okeke Claudia C
Jul/Aug 2008 Pg. 364	Zirconium Oxide Lotion Author(s): Allen Loyd V Jr
Jul/Aug 2008 Pg. 365-367	Lack of Commercial Oral Drug Formulations for Children in Two Hospital Group Purchasing Agreements in France and Canada Author(s): Prot-Labarthe Sonia, Bussieres Jean-Francois, Barett Pierre, Bourdon Olivier, Brion Francoise
Jul/Aug 2008 Pg. 372-374	Chemical Stability of Perphenazine in Two Commercially Available Vehicles for Oral Liquid Dosage Forms Author(s): Gupta Vishnu D
Jul/Aug 2008 Pg. 375	PostScription: It Is Not Just What You Say…But How You Say It! Author(s): Reed-Kane Dana
Jul/Aug 2008 Pg. 286-292	Estriol: Women's Choice vs. A Manufacturer's Greed Author(s): Goodrum Jennifer
Jul/Aug 2008 Pg. 295-304	Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women Author(s): Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K, Pinson Barbara, Price Carol
Jul/Aug 2008 Pg. 306-309	The Magic of Magnesium Author(s): Boomsma Diane
Jul/Aug 2008 Pg. 310-315	Progesterone and Traumatic Brain Injury: A Review of Literature Author(s): Williams LaVonn A, Mead Jay H
Jul/Aug 2008 Pg. 316-320	Beyond-Use Dating, Labeling, Delivery, and Storage of Compounded and Repackaged Mediations in a Hospital or Institutional Setting Author(s): McElhiney Linda F
Jul/Aug 2008 Pg. 321-327	Microbial Air-Sampling Equipment, Part 2: Experiences of Compounding Pharmacists Author(s): Mixon Bill, Cabaleiro Joe, Latta Kenneth S, Vail Jane
Jul/Aug 2008 Pg. 329-333	Recommendations for Overcoming Barriers to Medication Therapy Management Implementation, Part 1: Review of Literature Author(s): Fyke Jeremy P, Yale Robert N, Corbett Corinne, Litera Natalie
Jul/Aug 2008 Pg. 334-337	Using Readily Available Technology to Start or Enhance Pharmacy-Based Immunization Author(s): Westrick Salisa C, Felkey Bill G
Jul/Aug 2008 Pg. 338-339	Marketing for Your Community Author(s): Storey Patricia L
Jul/Aug 2008 Pg. 340-343	Quality-Control Analytical Methods: Homogeneity of Dosing Forms Author(s): Kupiec Thomas C, Vu Nicole, Branscum David
Jul/Aug 2008 Pg. 354	Calculations Author(s): Stockton Shelly J
Jul/Aug 2008 Pg. 355	Chloroxylenol 1% and Chlorhexidine Diacetate 1% Topical Powder Author(s): Allen Loyd V Jr
Jul/Aug 2008 Pg. 356	Silicone Cream Author(s): Allen Loyd V Jr
Jul/Aug 2008 Pg. 357	Sodium Chloride 0.9% Ointment Author(s): Allen Loyd V Jr
Jul/Aug 2008 Pg. 358	Squalene 0.2% Cream Author(s): Allen Loyd V Jr
Jul/Aug 2008 Pg. 359	Sucralfate and Hyaluronic Acid Ointment Author(s): Allen Loyd V Jr
Jul/Aug 2008 Pg. 360	Tretinoin and (-)Alpha-Bisabolol Gel Author(s): Allen Loyd V Jr
Jul/Aug 2008 Pg. 361	Tretinoin and Dexpanthenol Gel Author(s): Allen Loyd V Jr
Jul/Aug 2008 Pg. 362	Ultrasonic Adhesive Gel Author(s): Allen Loyd V Jr
Jul/Aug 2008 Pg. 363	Vitamin A Suppository Author(s): Allen Loyd V Jr
Jul/Aug 2008 Pg. 368-371	Physical and Chemical Stability of Palonosetron Hydrochloride with Glycopyrrolate and Neostigmine During Simulated Y-Site Administration Author(s): Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
Sep/Oct 2008 Pg. 382	PreScription: Compounding Around the World Author(s): Allen Loyd V Jr
Sep/Oct 2008 Pg. 384-390	Canine Public Servants: Caring for Drug Detection Dogs Author(s): Davidson Gigi S
Sep/Oct 2008 Pg. 392-397	Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases Author(s): Mixon William, Helms Scott R
Sep/Oct 2008 Pg. 398-401	Veterinary Compounding for Myasthenia Gravis Author(s): Davidson Gigi S
Sep/Oct 2008 Pg. 402-404	Equine Anesthesia: Triple Drip Author(s): Davidson Gigi S
Sep/Oct 2008 Pg. 405-409	Publication Expansion of United States Pharmacopeial Convention's Veterinary Standards and Clinical Information Author(s): Neal Amy S, DeVeau Ian, Schnatz Rick G
Sep/Oct 2008 Pg. 410-413	Golden Ticket to the United States Pharmacopeial Convention's Veterinary Internship Author(s): Kirk Loren Madden
Sep/Oct 2008 Pg. 444-445	Calculations Author(s): Stockton Shelly J
Sep/Oct 2008 Pg. 446	Aceclofenac 1.5% Gel-Cream Author(s): Allen Loyd V Jr
Sep/Oct 2008 Pg. 456-459	Testing the Long-Term Stability of Vancomycin Ophthalmic Solution Author(s): McLellan Christine, Ngo Van, Pasedis Sophia, Dohlman Claes H
Sep/Oct 2008 Pg. 460-462	Compatibility and Stability of Palonosetron Hydrochloride with Lactated Ringer's, Hetastarch in Lactated Electrolyte, and Mannitol Injections During Simulated Y-Site Administration Author(s): Ben Michel, Kupiec Thomas C, Trusley Craig, Trissel Lawrence A
Sep/Oct 2008 Pg. 463-466	Chemical Stability of Admixtures Combining Ziconotide with Fentanyl or Sufentanil During Simulated Intrathecal Administration Author(s): Shields David E, Aclan Jennifer, Szatkowski Aaron
Sep/Oct 2008 Pg. 414-418	Medication Therapy Management Implementation, Part 2: Study Methodologies, Barriers, and Recommendations to Overcome Barriers Author(s): Fyke Jeremy P, Yale Robert N, Corbett Corinne, Litera Natalie
Sep/Oct 2008 Pg. 420-424	Insurance for the Compounding Pharmacy Business, Part 1: Who Is Covered? Author(s): Baker Kenneth R
Sep/Oct 2008 Pg. 426-430	Excipient Choices for Special Populations Author(s): Nagel-Edwards Karen M, Ko James Y
Sep/Oct 2008 Pg. 432-433	Obtaining Accreditation by the Pharmacy Compounding Accreditation Board, Part 4L Tips for "Last Minute" Preparations Author(s): Cabaleiro Joe
Sep/Oct 2008 Pg. 434-437	Technology for the Patient-Centric Pharmacy Author(s): Felkey Bill G
Sep/Oct 2008 Pg. 447	Acetaminophen 10-mg/mL Rectal Solution Author(s): Allen Loyd V Jr
Sep/Oct 2008 Pg. 448	Carnitine 400-mg/mL and Coenzyme Q10 10-mg/mL Solution Author(s): Allen Loyd V Jr
Sep/Oct 2008 Pg. 438-439	Marketing: Taking Your Show on the Road Author(s): Storey Patricia L
Sep/Oct 2008 Pg. 440-443	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 9: Immediate-Use Compounded Sterile Preparations Author(s): Allen Loyd V Jr, Okeke Claudia C
Sep/Oct 2008 Pg. 449	Dichlorobenzyl Alcohol Tooth Gel Author(s): Allen Loyd V Jr
Sep/Oct 2008 Pg. 450	Estradiol 0.1% Vaginal Solution Author(s): Allen Loyd V Jr
Sep/Oct 2008 Pg. 451	Flurandrenolide Topical Film Author(s): Allen Loyd V Jr
Sep/Oct 2008 Pg. 452	Ketoprofen 20% Topical Solution Author(s): Allen Loyd V Jr
Sep/Oct 2008 Pg. 453	Lidocaine Adhesive System Gel Author(s): Allen Loyd V Jr
Sep/Oct 2008 Pg. 454	Piroxicam 5% and Dexpanthenol 5% Gel Author(s): Allen Loyd V Jr
Sep/Oct 2008 Pg. 455	Propafenone 1.5-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Sep/Oct 2008 Pg. 467	PostScription: The International Society of Pharmaceutical Compounding: A Discussion of Its Importance from the Perspective of ISPhC Leadership Author(s): Marro Diego, Barbosa Carlos Mauricio
Nov/Dec 2008 Pg. 474	Prescription: Is "Globalization" a Good Idea? Author(s): Allen Loyd V Jr
Nov/Dec 2008 Pg. 476-480	Arthritis Epidemiology Impacts Pharmacists Author(s): Vance Dwight A
Nov/Dec 2008 Pg. 482-487	Compounding Challenges for Immunocompromised Patients Author(s): McElhiney Linda F
Nov/Dec 2008 Pg. 498-504	Case Reports: Compounding to Relieve Arthritis Pain Author(s): Marshall Robert, Vidaurri Vincent A, Boomsma Diane, Buchta Anthony J, Vail Jane
Nov/Dec 2008 Pg. 505-507	Symbols: Historic and Current Uses Author(s): Bailey Emilee
Nov/Dec 2008 Pg. 508-513	Medication Therapy Management Implementation, Part 3: Barriers and Recommendations to Overcome Barriers Author(s): Fyke Jeremy P, Yale Robert N, Corbett Corinne, Litera Natalie
Nov/Dec 2008 Pg. 524-528	Quality-Control Analytical Methods: Overview of Beyond-Use Dating for Compounded Sterile Preparations Author(s): Trissel Lawrence A
Nov/Dec 2008 Pg. 539	Calculations Author(s): Stockton Shelly J
Nov/Dec 2008 Pg. 542	Glycerin, Sterile Author(s): Allen Loyd V Jr
Nov/Dec 2008 Pg. 543	Indomethacin 2% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Nov/Dec 2008 Pg. 544	Ketorolac Tromethamine 2% Topical Gel Author(s): Allen Loyd V Jr
Nov/Dec 2008 Pg. 546	Liothyronine Sodium (T3) 5-mcg/0.1-mL Transdermal Cream Author(s): Allen Loyd V Jr
Nov/Dec 2008 Pg. 488-497	Differentiation and Treatment of Hypothyroidism, Functional Hypothyroidism, and Functional Metabolism Author(s): Paoletti Jim
Nov/Dec 2008 Pg. 514-523	Insurance for the Compounding Pharmacy Business, Part 2: What, When, and Where Author(s): Baker Kenneth R
Nov/Dec 2008 Pg. 537-538	Branding: Give Your Small Business a Big Image Author(s): Storey Patricia L
Nov/Dec 2008 Pg. 540	Cyclobenzaprine Hydrochloride 0.5% and Diclofenac Sodium 3% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Nov/Dec 2008 Pg. 541	Cyclobenzaprine Hydrochloride 1%, Dextromethorphan Hydrobromide 10%, Guaifenesin 10%, and Indomethacin 20% Penetrating Gel Author(s): Allen Loyd V Jr
Nov/Dec 2008 Pg. 545	Liothyronine Sodium (T3) 5-mcg/Hydrocortisone 5-mg Slow-Release Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2008 Pg. 547	Liothyronine Sodium (T3) 5-mcg/Selenium 100-mcg Slow-Release Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2008 Pg. 548	Liothyronine Sodium (T3) 5-mcg Slow-Release Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2008 Pg. 549	Morphine Sulfate 20-mg and Prochlorperazine Maleate 10-mg Troches Author(s): Allen Loyd V Jr
Nov/Dec 2008 Pg. 550-552	Physical Compatibility and Chemical Stability of a Concentrated Solution of Atropine Sulfate (2 mg/mL) for Use as an Antidote in Nerve Agent Casualties Author(s): Donnelly Ronald F, Corman Celine
Nov/Dec 2008 Pg. 553-557	Chemical Stability of Admixtures Containing Ziconotide 25 mcg/mL and Morphine Sulfate 10 mg/mL or 20 mg/mL During Simulated Intrathecal Administration Author(s): Shields David E, Aclan Jennifer, Szatkowski Aaron
Nov/Dec 2008 Pg. 565	PostScription: Supporting Compounding Around the World Author(s): Allen Loyd V Jr
Nov/Dec 2008 Pg. 530-536	Basics of Compounding: United States Pharmacopeia General Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 10: First Revision: The Main Changes, Events, and Rationale Author(s): Okeke Claudia C, Newton David W, Kastango Eric S, Allen Loyd V Jr
Nov/Dec 2008 Pg. 558-564	Stability of Metronidazole Benzoate in SyrSpend SF One-Step Suspension System Author(s): Vu Nicole T, Aloumanis Vasileios, Ben Michel J, Kupiec Thomas C, Patterson Evelyn K, Radke Joshua, Erickson Martin A III, Schneider Gary